These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35431259)

  • 1. Spinal Muscular Atrophy - Is Newborn Screening Too Late for Children with Two SMN2 Copies?
    Schwartz O; Kölbel H; Blaschek A; Gläser D; Burggraf S; Röschinger W; Schara U; Müller-Felber W; Vill K
    J Neuromuscul Dis; 2022; 9(3):389-396. PubMed ID: 35431259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
    Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W
    Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?
    Müller-Felber W; Vill K; Schwartz O; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Durner J; Eggermann K; Müller C; Hannibal I; Olgemöller B; Schara U; Blaschek A; Kölbel H
    J Neuromuscul Dis; 2020; 7(2):109-117. PubMed ID: 32144995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn Screening for SMA - Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?
    Blaschek A; Kölbel H; Schwartz O; Köhler C; Gläser D; Eggermann K; Hannibal I; Schara-Schmidt U; Müller-Felber W; Vill K
    J Neuromuscul Dis; 2022; 9(5):597-605. PubMed ID: 35848034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns.
    Efimova IY; Zinchenko RA; Marakhonov AV; Balinova NV; Mikhalchuk KA; Shchagina OA; Polyakov AV; Mudaeva DA; Saydaeva DH; Matulevich SA; Parshintseva PD; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Jamschikova AV; Nurgalieva LR; Saifullina EV; Nevmerzhitskaya KS; Belyaeva TI; Romanova OS; Voronin SV; Kutsev SI
    Pediatr Neurol; 2024 Jul; 156():147-154. PubMed ID: 38781723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
    Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2.
    Vill K; Tacke M; König A; Baumann M; Baumgartner M; Steinbach M; Bernert G; Blaschek A; Deschauer M; Flotats-Bastardas M; Friese J; Goldbach S; Gross M; Günther R; Hahn A; Hagenacker T; Hauser E; Horber V; Illsinger S; Johannsen J; Kamm C; Koch JC; Koelbel H; Koehler C; Kolzter K; Lochmüller H; Ludolph A; Mensch A; Meyer Zu Hoerste G; Mueller M; Mueller-Felber W; Neuwirth C; Petri S; Probst-Schendzielorz K; Pühringer M; Steinbach R; Schara-Schmidt U; Schimmel M; Schrank B; Schwartz O; Schlachter K; Schwerin-Nagel A; Schreiber G; Smitka M; Topakian R; Trollmann R; Tuerk M; Theophil M; Rauscher C; Vorgerd M; Walter MC; Weiler M; Weiss C; Wilichowski E; Wurster CD; Wunderlich G; Zeller D; Ziegler A; Kirschner J; Pechmann A;
    J Neurol; 2024 May; 271(5):2787-2797. PubMed ID: 38409538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early spinal muscular atrophy treatment following newborn screening: A 20-month review of the first Italian regional experience.
    Gagliardi D; Canzio E; Orsini P; Conti P; Sinisi V; Maggiore C; Santarsia MC; Lagioia G; Lupis G; Roppa I; Scianatico G; Mancini D; Corti S; Comi GP; Gentile M; Gagliardi D
    Ann Clin Transl Neurol; 2024 May; 11(5):1090-1096. PubMed ID: 38600653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.
    Monani UR; Sendtner M; Coovert DD; Parsons DW; Andreassi C; Le TT; Jablonka S; Schrank B; Rossoll W; Prior TW; Morris GE; Burghes AH
    Hum Mol Genet; 2000 Feb; 9(3):333-9. PubMed ID: 10655541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
    Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
    Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
    Glascock J; Sampson J; Haidet-Phillips A; Connolly A; Darras B; Day J; Finkel R; Howell RR; Klinger K; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2018; 5(2):145-158. PubMed ID: 29614695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?
    Chen TH
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Variability in the Survival Motor Neuron Genes (
    Butchbach MER
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
    Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
    J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches.
    Nizzardo M; Simone C; Dametti S; Salani S; Ulzi G; Pagliarani S; Rizzo F; Frattini E; Pagani F; Bresolin N; Comi G; Corti S
    Sci Rep; 2015 Jun; 5():11746. PubMed ID: 26123042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy.
    Aslesh T; Yokota T
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy.
    Alves CRR; Zhang R; Johnstone AJ; Garner R; Nwe PH; Siranosian JJ; Swoboda KJ
    Neurology; 2020 Mar; 94(9):e921-e931. PubMed ID: 31882526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.